e-TENDER SCHEDULE

,
Headquarters, Employees’ State Insurance Corporation ,
Ministry of Labour & Employment, Government of India.
,.. : -110002. Panchdeep Bhawan: C.I.G. Road: New Delhi – 110 002
-/ email: [email protected]
/ TelFax: 011-23234334
No.U-25/12/142C-146C/2019-Med.V Dated: 11.02.2021
Corrigendum
E-TENDER ENQUIRY FORM FOR RATE CONTRACT NO 142C, 143C, 144C, 145C, 146C & 147B
FOR SUPPLY OF DRUGS & DRESSINGS.
e-TENDER SCHEDULE
It is hereby informed to all Participating Pharmaceuticals Firms that Last date of online Bid submission, Manual submission of EMD, Labels & Integrity Pact and Opening of Technical Bid has been extended as detailed below:-
S.No. Details Existing Dates & time Extended Date & Time
1. Last date of Online bid
submission & Manual submission of EMD, Labels &
Integrity Pact
15.02.2021 upto 10.00 AM. 06.03.2021 upto 10.00 AM
2. Opening of Technical Bid 142C- 16.02.2021 at 10.00 AM 143C- 16.02.2021 at 11.00 AM
144C- 16.02.2021 at 12.00 Noon 145C- 16.02.2021 at 02.00 PM
146C- 16.02.2021 at 04.00 PM
147B- 16.02.2021 at 04.00 PM
142C- 08.03.2021 at 10.00 AM 143C- 08.03.2021 at 11.00 AM 144C- 08.03.2021 at 12.00 Noon 145C- 08.03.2021 at 02.00 PM 146C- 08.03.2021 at 03.00 PM 147B- 08.03.2021 at 04.00 PM
Prebid Meeting in respect of e-Tender Enquiries 142C-146C & 147B for supply of Drugs & Dressings was
held on 19.01.2021 and the clarification regarding query/ issue raised by the Participating Pharmaceutical
firm(s) are as under:-
Sno Clause of TE Query/ Issue Name of the Firm Remarks Decision
1 Clause no 2 :
142C to 146C & 147B requested as firm is
registered under MSME.
already exists at Clause No 2
(VIII) of respective Tender
Office Memorandum F.9/4/2020-PPD
Finance, Deptt of Expenditure,
Morepen Laboratories Ltd No Change in existing Policy. Not Accepted
2 Bank
in the tender. Also provide copy of GS Tin
no , Pan number & Bank Details of ESIC.
Astra Zeneca Pharma India
should be 3% of the contract value as
discussed in Pre bid meeting. Where as in
the above said tender the value mention is
Turn Over value not the contract value.
Mankind Pharma Ltd The item-wise Turn Over value
mentioned in the respective
Tender Enquiries is for
information to the Participating
Pharmaceutical firm to submit
value of the item.
,
/ TelFax: 011-23234334
Sno Clause of TE Query/ Issue Name of the Firm Remarks Decision
4 Clause No 9
keep minimum Performance Security as
Rs. 2 Lakhs / Rs. 5 Lakhs, as the same has
already been implemented in ESIC’s
Ayurvedic Rate Contract.
Micron Pharmaceuticals
Pfizer Ltd
stipulated time for releasing of EMD &
PSD.
exists at Clause No 2 (X) of
respective Tender Enquiries.
Additional condition in
Users and No pending
instead of DCGI approval for all items
quoted.
only for the fixed dose combination or for
the new drugs or for the products
imported first time in India.
Dr. Reddy’s Laboratoires Ltd Clause 5(XVIII) may be
read as:-
Act and the existing laws there
under).
Drugs (as per Drug &
laws there under).
MSN Laboratories Private
Overseas Healthcare Pvt Ltd
To clarify whether the firm shall quote
product for which DCGI approval is
pending along with copy of the application
submitted to DCGI (DCGI acknowledged
copy).
Page 2 of 28
,
/ TelFax: 011-23234334
Sno Clause of TE Query/ Issue Name of the Firm Recommendations Remarks
7 Clause 5 (VII)
either Patent Certificate/ Proprietary
Certificate or Sole Manufacturing
Licensing Authority.
Authority has been asked and these such
certificates are issued by Ministry of
commerce & Industry, Govt of India.
Further firm stated that there are high
chances that patented products are not
manufactured in India. Firm requested to
allow PAC certificate holders to participate
in the tender.
be read as:-
Proprietary certificate from the
Patent office / State Drug
Licensing Authority to this
not be considered.
For Imported Drugs-
Certificate from Patent Office /
not be considered.
Certificate (PAC) and it shall also be
accepted as the letter / information given
by the overseas manufacturer as truthful
with all their responsibility and can fulfil
your requirements.
Serdia (India)
Pharmaceuticals Pvt Ltd
8 Fall Clause Removal of Fall Clause- as per letter of
Ministry of Chemical & Fertilizers no
31026/2019- Policy dated 04.09.2020.
respective Tender Enquiries.
have gone OFF PATENT:-
70mg
clause 5 (V), the following
is added:-
ago from the last date of bid
submission:-
Patent Office.
Each Tab/Cap to contain: 143 mcg
Indacaterol Maleate Eqv. to 110 mcg
Indacaterol & 63 mcg Glycopyrronium
The same has also been adopted by
DGHS, Delhi Govt.
Tab/Cap Vildagliptiin 50mg / Vildagliptin
Vildagliptin 50mg Metformin HCL IP 1000
mg-
DGHS, Delhi Govt.
Macleods Pharmls Ltd
Eris Lifesciences limited
Psychotropics India Limited
,
/ TelFax: 011-23234334
10 Annexure B &
B & D as per format issued by State Drug
Controller.
Licensing Authority format
requisite information as
respective TE's.
reference/ authentication of products.
recommended.
MG, Firm stated that this is new Product of
COVID 19 and no company is having MMC,
Annexure B&D ( Manufacturing
Macleods Pharmaceuticals
(V) of respective Tender
of a product is shifted to the another
factory of the same manufacturer and
some time the product is manufactured by
a manufacturer since last 5 year but in a
single year no batch has been
manufactured may be due to no demand
or shortage of raw material.
Morepen Laboratories
last three continuous years for
the product(s) quoted
irrespective of manufacturing
plant along with new plant MMC. Also, the
production of last 3 years in 5 years
should be considered.
recommended.
is Rs. 8 Crore only. Annual demand was
around Rs. Rs. 69515428. In the current
tender annual turnover is Rs. 434471000/-
. Requested to keep turnover Rs. 8 Crore.
Paviour Pharmaceuticals Pvt
Albumin 20%- Turnover i.e. Rs.
434471000/- for this item has been kept
on a very higher side which would abstain
many importers to participate as this
turnover can only be maintained by
manufacturers.
such drugs. These are used in some most
critical life saving conditions and do not
enjoy huge volume sales.
Products alongwith various other products
may be eligible to meet the Annual
turnover clause but the firm who are
typically specialized and pioneers in Blood
Plasma products will be deprived to
participate in the bid which may lead to
impose gross monopoly by those few
eligible companies.
the same products. The turnover
requirement is much lesser or the turnover
of the principal manufacturer is
considered.
,
/ TelFax: 011-23234334
11 Contd.. For item no 1409a, 1410a, 1411a, 1455a,
1455b- TE 144c
criteria of Company Turnover
ESIC rather than each items with
restrictive Turnover and EMD Criteria.
Accordingly please amend the Turnover
Criteria to Rs.10Cr for the Company and
EMD @2% for the tentative procurement
value by Bank Guarantee
recommended.
Rs. 122,64,44,000/- Analgesic Cream-
requested to kindly reduces turnover for
item no 1866 to receive more bidder for
this items.
Hab Pharmaceuticals &
Research Limited
1265a, TE 146C, Antiseptic Liquid-500ml-
to reduce 5 Cr
The Swastik Pharmaceuticals
For item no 1411a, CAPD Fluid 4.25% is only Manufactured by Mitra Industries and for that the annual Turnover has been put as INR 50Cr , EMD INR 50L and PBG INR 30L, We had not quoted in the last tender due this Condition. Procurement of this specialised fluid concentration may not be possible due to this.
Mitra Industries Pvt Ltd. Criteria for Annual Turnover,
EMD & Performance Security
which have not been
quoted/awarded since RC 142
Accepted
Annual
12 Annual
Alpha Drugs As the Principal Manufacturer
is not a direct bidding party in
the tender process of ESIC , it
has no locus standii in the
tender.
recommended.
,
/ TelFax: 011-23234334
13
Turnover
requirement
mainly, negligible demand of this product
in open market so 50% of the annual
turnover is not possible in open market for
the prospective bidders who are marketing
these lifesaving drugs only.
the point may please be relaxed in case of
imported lifesaving medicines.
saving item at Private/
recommended.
2017-18 & 2018-19 whereas it shall
be 2017-18, 2018-19, 2019-20 since
this period is also mentioned on
MMC.
turnover required is for last three
preceding Financial Years viz 2017-
18, 2018-19 & 2019-20 or the
condition mentioned in the TE shall
prevail.
Participating
change in period of
quoted products are imported drugs. Firms
clarified that these products are tested and
released by in-house international
specifications that are registered with Drug
Controller General (India) office while
getting the product registered import into
India. Firm requested to allow to submit
in-house test and analysis batch reports in
lieu of test report from Govt./ Govt
approved Laboratories.
added:-
available in India:-
Government owned
testing of the said drug is not
available in India.
submitted by the firm for each
batch at the time of supply.
Modified and a
batches of medicines only in case of big
quantities or upto to certain value of
supplies
recommended.
GLP Certificate as is being done by other
government institutions like AIIMS, New
Delhi / RML & SJH/ Delhi Government
Hospitals
being done by other autonomous
institutions like AIIMS also give exemption
for submitting NABL Testing if the value of
the order is below Rs. 10000/-
Wallace Pharmaceuticals
Pvt Ltd
report on the values of order more than
50000 Rupees or as ESIC consider.
CMG biotech Pvt Ltd.
outsource lab will certainly increase the
price offered to the ESIC.
Limited Psychotropics India
,
/ TelFax: 011-23234334
15 Authorized
Distributor as
in other
(DGAFMS) etc
Not Accepted
For Zone - distributor should be allowed Essity India Private Limited
Lupin Ltd
Pulse Pharmls
definition/classification of New Drug and
which regulatory document would be
sufficient (like form 28 or form 46) &
would only form 46 be sufficient
Cadila Healthcare Limited Valid Permission for the new
drug from DCGI & Valid
Manufacturing Licences for the
Drug Licensing Authority as
prescribed in Drug & Cosmetic
Clarified
no 2 be exempted.
17 Clause no 4
prices due to restriction of import license
from china goods validity of Rate Contract
should be for one year & may be extended
for 06 to 12 months
Zim Laboratories Limited No Change in existing Policy. Not Accepted
18 Clause no 1
to allow to submit colour scan copies of
images of outer cartons. Original drug will
be brough and show in the office & when
required.
carton, and if we peel off the label from
the bottle, it will damage and get defaced.
Requested to submit the bottle pack of
that product.
,
/ TelFax: 011-23234334
19 Clause 5 (IV)
imported and mfd outside India and from
different countries Germany, Switzerland,
sites. Firm requested to advise on this
clause for imported drugs.
is added:-
manufacturing sites for the
product(s) quoted along with
notarized translation in English
by the authorised translator.
Laboratory Practice) is not issued by their
Drug Regulatory Department, instead they
issue the GMP Certificate to their
Manufacturing Units considering their
includes the GLP facility. Since we are also
quoting the Imported products and
therefore requires exemption for
submitting COPP fulfilling the requirement.
Johnson & Johnson
Serdia (India)
their inability to provide GLP issued by
Drug control authorities in India. valid
Import licence from DCGI & GMP were
certificate
period from the date of receipt of order.
As the situation & availability of basic
drugs & packing material in domestic
market not in control. They is irregularity
in supply of RM/PM and future condition
uncertain.
Zim Laboratories Limited No Change in existing Policy. Not Accepted
increased to 8 weeks from 6 weeks as
testing protocols for injectables takes 14-
18 days.
possible for any of the firm as the sterility
products is 30 days for many products,
hence it should be 60 days for sterile /
Injectable products and 42 days for the
Tablet/Cap/Oint/Syrup etc.
Psychotropics India
some reasonable value (Rs. 3000/-)
Unimarck Pharma (India)
Page 8 of 28
,
/ TelFax: 011-23234334
22 Clause I & J-
requested confirmation to provide this
undertaking with respect to products being
quoted in the tender(s).
Annexure-E may be read in
context to litigation cases with
respect to
and/or
Non Conviction Certificate
(II) should be submitted
Checklist in the respective
years with any other Company in any
Country conforming to the anti-corruption
approach….Firm requested for
India instead of any Country.
Astra Zeneca Pharma
24 ESIC coverage Alcon India is an importer & marketer of
the products in India. Alcon India does
not have any factory/manufacturing unit in
India. gross salaries of all employees is
more than 21,000/- pm which is the ESIC
coverage bracket at Alcon Laboratories
(India) Pvt. Ltd. So we do not fall under
any of the criteria. Please guide us for the
document required in this case.
Alcon Laboratories (India)
certificate from the respective
Regional Director, ESIC that
the office/unit is not
coverable under ESI Act.
Indoco Remedies Limited Drug Licence or GST Number
or Rent Receipt in the name of
the Participating
various locations and submitting only the
Depot details and had more then one
depot in some zones, shall they submit
details of all depots for each zone.
Astra Zeneca Pharma
due to unforeseen circumstances i.e.
lockdown, closing of transportation and
restriction of factory working due to Covid-
19 pandemic.
Implemented
should be acceptable with undertaking.
Already
Implemented
RC -NO. 144B
be deleted.
,
/ TelFax: 011-23234334
29 Clause 19 (I)
Clause no 17 Page no 16 – It is stated that
a penalty of Two (2) per cent of the value
of the order calculated at the contract rate
per week or a part of a week will be
levied.
Clause no 19 Page no 17 – It is stated that
Payment for the supply will be made
within 4 to 6 weeks (after receipt and
acceptance of the drugs/items)
only be applicable if the payments are also
released within 4 to 6 weeks
Payment of the bills should be arranged
expeditiously within 4-6 weeks and there
should not be unnecessary delay. Further
firm stated that they also received orders
from the institution even without clearing
the older pending bills. Firm requested to
add clause for penalize the both parties in
such delayed terms.
seriously and resolved quickly.
deducting the payment if we are failed to
supply within 42 days (Specified Time)
whereas there is no guarantee or specified
period in which we will get back our
money. In all received payment we are not
getting payment advice.
Abbott Healthcare Pvt Ltd No Change in existing Policy. Not Accepted
Abbott India Ltd
from various locations of ESIC
The DDO’s of ESIC / ESIS most of time
delayed the release of payment and even
after release, no details about TDS & LD
charges if any are given along with the
payments for confirmation and difficult to
adjust against our pending Invoices since
it comes from one mail ID and not even
specify the location
locations payments are very delay up to
300 plus days. No details of the payment
receipts from various locations of ESIC
Wallace Pharmaceuticals Pvt
be removed as ESIC is a complex structure
and every company can’t comply.
Pfizer Products India Pvt Ltd All Bids will be processed as
per GFR and CVC guidelines.
Clarified.
quoted the lowest price and than also rate
contract has not been awarded and the
products are again published in this TE.
Firm requested to know that onward
grounds and on what selection criteria the
rate contract was not awarded while
giving the crores of EMD to ESIC.
Psychotropics India Limited
,
/ TelFax: 011-23234334
30 Contd../- Item no 1546, TE 142B, Firm stated that
they had quoted the said item and
declared L1 @ 109/- but inspite of giving
lowest possible rate and the previous RC
was 140.57/- , rate contract was not
awarded. Many representations has
Firm requested to confirm purchasing
criteria and selection criteria for this
tender, so that they should quote the
products accordingly and out funds
shall not be stucked with ESIC.
Hab Pharmaceuticals
& Research Limited
the items with single bids are not
finalized and kept on hold. Further firm
stated that keeping in mind the vast
coverage of ESI and prompt services to
various ESI Hospitals many bidders don’t
participate for certain products which
lead to single bidder situation. Firm
requested that the tender should be
finalized for single bids as well.
Baxter (India) Pvt
Ltd.
terms & conditions of respective TE's.
However seeking any documentation
Competent Authority and as per
prescribed procedure.
31 Pack Size For item no 1703, TE 146C, Terbinafine
ointment - Change required oint/cream
Terbinafine Ointment -
1%
BOQ as:
Terbinafine Ointment/Cream -
1%
Accepted
BP include in Adapalene 0.1% and USP
replace with IP for clindamycin
Curetech Skincare Accepted. Any pharmacopeia i.e
IP/BP/USP etc may be considered
equivalent for derivation of lowest
bidder. This will be applicable to all
drugs in respective Tender Enquiries.
Existing in TE (Drug Schedule & BOQ) :
Acne Gel-
w/w (As Microsheres) Clindamycin
Phosphate USP Equivalent To
Gel Base -Q.S.
BOQ as:
Acne Gel-
IP/BP/USP etc w/w (As Microsheres)
Clindamycin Phosphate IP/BP/USP etc
an Aqueous Gel Base -Q.S.
Page 11 of 28
,
/ TelFax: 011-23234334
31. Pack Size /
Pyrazinamide 300mg- to accept
Pyrazinamide Kid Tab/Cap-
Pyrazinamide 300mg
BOQ as:
Pyrazinamide Kid
PLAIN/DISPERSIBLE Tab/Cap-
change specification to Self Collapsible
container in FFS Technology.
Ringer Lactate Inj-
Amended to be read in Drug Schedule &
BOQ as:
Self Collapsible IV Fluid PVC Bag/ Self
Collapsible container (FFS
Collapsible container in FFS Technology.
Aculife Healthcare
Private Limited
DNS Inj-
Collapsible IV Fluid Bag
BOQ as:
DNS Inj-
Self Collapsible container in FFS
Technology
Dextrose 5% Inj (IV Fluids)-
Each to contain: Dextrose 5% Self
Collapsible I.V. Fluid Bag
BOQ as:
Each to contain: Dextrose 5% Self
Collapsible I.V. Fluid Bag/ Self
,
/ TelFax: 011-23234334
31. Pack Size /
Filgrastim 6mg
Existing in TE(Drug Schedule & BOQ) :
Item Name and Description:- Peg-Filgrastim Inj-
Each PFS to contain: Peg-Filgrastim 6mg
Unit- 1ml PFS
Item Name and Description:- Peg-Filgrastim Inj-
Each PFS to contain: Peg-Filgrastim 6mg
Unit- 1 PFS
PFS in price bid (BOQ). L1 will be derived on
per PFS basis.
Limited
Item no 1652b, TE 144C, Hepatitis B Immunoglobulin Inj - Each 1ml to contain:Inj. Hepatitis B Immunoglobulin 200 IU- different manufacturer has got different concentration of HBIG leading to 200iu in packing of 0.4ml to 2.0ml. Requested to amend it =< 0.5ml or remove the volume content.
Paviour
Accepted and Pack Size may be read as 1 vial.
Existing in TE(Drug Schedule & BOQ) :
Item Name and Description:- Hepatitis B
Immunoglobulin Inj- Each 1ml to contain: Hepatitis
B Immunoglobulin 200 IU
Item Name and Description:- Hepatitis B
Immunoglobulin Inj- Each Vial to contain: Hepatitis
B Immunoglobulin 200 IU
Vial in price bid (BOQ). L1 will be derived on
per Vial basis.
Ciprofloxacin Eye/Ear Drop
Change to 10ml
FDC Limited Accepted
Drop- Each Vial to contain: Ciprofloxacin 0.3% w/v.
Unit- 5ml Vial
Item Name and Description:-Ciprofloxacin Eye/Ear
Drop- Each Vial to contain: Ciprofloxacin 0.3% w/v.
5 to 10ml vial
ml in price bid (BOQ). L1 will be derived on
per ml basis.
Hydroxypropylmethylcellulos
vial - Change to 10ml
Item Name and Description:-
contain: Hydroxypropylmethylcellulose 0.3%
Unit- 5ml Vial
contain: Hydroxypropylmethylcellulose 0.3%
ml in price bid (BOQ). L1 will be derived on
per ml basis. Alcon Laboratories
(India) Pvt Ltd.
,
/ TelFax: 011-23234334
Firm
3% w/w, Ammonium Chloride 0.5%
w/w, Sod. Chloride 0.5% w/w,
Potassium Chloride 0.5% w/w, Calcium
Lactate 0.5% w/w, Magnesium Chloride
0.3% w/w, Sod. Dihydrogen Phosphate
0.5 % w/wpack 50gm - Change to 75gm
Jar.
:Item Name and Description:- Urea+
Lactic Acid Cream- Each Jar to contain:
Urea 12% w/w, Lactic Acid 6% w/w,
Glycine 3% w/w, Ammonium Chloride
0.5% w/w, Sod. Chloride 0.5% w/w,
Potassium Chloride 0.5% w/w, Calcium
Lactate 0.5% w/w, Magnesium Chloride
0.3% w/w, Sod. Dihydrogen Phosphate
0.5 % w/wUnit- 50 gm Jar
BOQ as: Item Name and Description:-
Urea+ Lactic Acid Cream- Each Jar to
contain: Urea 12% w/w, Lactic Acid 6%
w/w, Glycine 3% w/w, Ammonium
Chloride 0.5% w/w, Sod. Chloride 0.5%
w/w, Potassium Chloride 0.5% w/w,
Calcium Lactate 0.5% w/w, Magnesium
Chloride 0.3% w/w, Sod. Dihydrogen
Phosphate 0.5 % w/w
price per gm in price bid (BOQ). L1
will be derived on per gm basis.
Accepted
to 10gmcontaining per gm
Item Name and Description:- Polymixin,
Neomycin Eye Oint- Each gm to contain:
Polymixin B Sulphate 5000 IU, Neomycin
Sulphate 3400 IU, Zinc Bacitracin 400 IU
Unit- 5 gm Tube
BOQ as:
Polymixin B Sulphate 5000 IU, Neomycin
5gm to 10gm Tube
Item no 1709, TE 144C, Tacrolimus oint
0.1% pack 10 gm - Change to 5gm
Ajanta Pharma Ltd Accepted
Item Name and Description:-Tacrolimus
0.1%
BOQ as:
0.1%
Page 14 of 28
,
/ TelFax: 011-23234334
Firm
contain: Brinzalamide 1%- The item name
should be Brinzolamide 1%Eye Drop
Novartis Accepted
Item Name and Description:--Brinzalamide
Brinzalamide 1%
BOQ as:
contain: Brinzolamide 1%
contain : Liposomal Amphotericin -B P
50mg (Lyophilized) – changed to
saline suspension)
ADHESIVE TAPE - Paper Adhesive Tape
Hypoallergenic with Acrylate Adhesive
Adhesive Tape with Acrylate Adhesive.
Essity India Private
40mg/0.8ml: Requesting to change the
specification as per pharmacopeia.
32. Shelf Life Item no 587b, TE 145C- Sevoflurane inj –
Each 250 ml to contain Sevoflurane, shelf
life requirement is 2 years and requested
to amend shelf life as more than 3 years
Piramal
Enterprises
Limited
60mg to 60mcg
Dr. Reddy’s
Item Name and Description:--Darbepoetin
60mg
BOQ as:
60mcg
Accepted
PregabalinTab/cap : Each tab/cap to
Pregabalin Tab/Cap-
75mg.
BOQ as:
Pregabalin Tab/Cap-
Each PLAIN/SR/CR/DR/ER/MR
Item no 2305, TE- 143C, Trimetazine
Tab/cap - 60mg- Only SR/CR available
Inventia
Trimetazidine Tab/Cap-
60mg.
BOQ as:
Trimetazidine Tab/Cap-
Each PLAIN/SR/CR/DR/ER/MR
Page 15 of 28
,
/ TelFax: 011-23234334
Firm
Pulse
Pharmaceuticals
Accepted
Item Name and Description:--Calcium +
Calcium 500mg , Vitamin D3 500mg
BOQ as:
Calcium 500mg , Vitamin D3 500IU
Accepted
GSK for Nitrofurantoin Tablets l00mg
Overseas
Tab/Cap to contain:Nitrofuradantin 100mg
BOQ as:
Tab/Cap to contain:Nitrofurantoin
- DCGI office has aligned the
nomenclature in terms of mg instead of IU
& issue Import licence for 5.3mg. To add
5.3mg also along with 16IU.
Pfizer Products
Item Name and Description:-Human
contain: Somatropin 16 IU (R-DNA Origin)
BOQ as:
contain: Somatropin 16 IU (R-DNA Origin)
/ Somatropin 5.3mg (R-DNA Origin)
contain: Salbutamol 100 mcg.,
Beclomethasone Dipropionate 50 mcg.
beta2 adrenergic receptor agonist) and is
currently available SABA’s are Salbutamol
100 mcg & Levosalbutamol 50 mcg,
Cipla Ltd Not Accepted Not Accepted
Item no 396, TE – 146C- Silver
Sulphadiazine Oint, Vitamin E is not
permitted by DCGI, Firm requested to
delete Vitamin E
Oxide 5%. Firm suggested for correct
specification : Calamine 150g, Zinc Oxide
50g, Bentonite 30g, Sodium Citrate 5g,
Liquefied Phenol 5ml, Glycerin 50ml.
Nanz Med
Science Pharma
Pvt Ltd
instead of 15ml
1.53gm
25mg
,
/ TelFax: 011-23234334
33. Strength/
Vitamin C and Zinc Tab/Cap-
(with extra ingredients) i.e. Nicotinamide
45mg instead of 50mg and include extra
ingredient i.e. Niacin 15mg
Limited
contains: Terbutaline sulphate IP 1.25 mg
Ambroxol hydrochloride IP 15 mg
Guaiphenesin IP 50mg- Firm had added
Menthol which is only for flavoured base
and this will add soothing effect also.
Requested to allow to participate in this
mentioned item code.
Item no 1459, TE 143C- Cough Syp- Each
5ml to contain: Ambroxol Hydrochloride
30mg, Terbutaline Sulphate Eqv To
Terbutaline 1.25mg, Guaiphenesin 50mg,
amendment as per standard composition
of Ambroxol 15mg.
Item no 1050 sno 42 in TE 143C as our
composition does not have CITRIC ACID
5.8 MG IN OUR COMPOSITION, because
of CITRIC ACID is only BEDER solution not
a active ingredient.
34. Development
of Online
System of
mentioned in the Terms & Conditions of
your Tender Enquiry so that we shall get
the release of timely payments from the
consignee’s of ESI.
Policy.
issues for delay in getting the payments
from the various demanding places.
Currently the situation of getting the
payments is not as per the clause
mentioned therefore it is to be addressed
and create the guidelines for making the
payments to the companies as per the
payment clause.
payment receipts- Firm stated that ESIC is
making the payments through a single
bank account and they are unable to trace
the details / bill wise of the payments
made by ESIC for the supplies made to all
over India Hospitals.
advice so that the supplier can trace the
payments & avoid further reminders.
Midascare Pharmaceuticals Pvt Ltd
Hab Pharmaceuticals & Research Ltd
Rest of the Terms & Conditions of the tender will remain the same.
Encl:
1. Bank Guarantee Format for EMD (Page No. 18 & 19).
2. ESIC GST Number, ESIC Pan Number & ESIC Bank Details (page No. 20).
3. Demo BOQ for 142C to 146C & 147B (Page No -21 to 28).
Sd/- Dy. Medical Commissioner,
,
/ TelFax: 011-23234334
BANK GUARANTEE FORM FOR EARNEST MONEY DEPOSIT
To DIRECTOR GENERAL, ESIC HEADQUATERS OFFICE, CIG ROAD, NEW DELHI - 110002.
WHEREAS____________________________________________(Name and address of the Bidder) (Hereinafter called The Bidder)has undertaken, in pursuance of _____________________________________________________________________ Dated________ for Supply of ____________________. (Herein After Called The Tender Enquiry).
AND WHEREAS it is one of the terms of The Tender Enquiry that The Bidder has to submit a performance Bank Guarantee by a Commercial Bank for EMD.
AND WHEREAS it has been stipulated by ESIC in the said e-Tender Enquiry that The Bidder shall furnish ESIC with a Bank Guarantee by a Commercial Bank for the sum specified therein as EMD for compliance with obligations in accordance with The Tender Enquiry; AND WHEREAS we have agreed to give The Bidder such a Bank Guarantee; NOW THEREFORE we hereby affirm that we are guarantors and responsible to ESIC, on behalf of The Bidder, up to a total sum of Rs. _____________________(Amount of Bank Guarantee in words and figures), and we undertake to pay ESIC, upon ESIC first written demand declaring The Bidder to be in default under control and without demur cavil or argument, any sum or sums within the limits of (Amount of Bank Guarantee) as aforesaid, without ESIC needing to prove or to show grounds or reasons for ESIC demand or the sum specified therein.
A letter/ email from ESIC office that The Bidder has committed default in the due and faithful performance of all or any of its obligations under and in accordance with The Tender Enquiry shall be conclusive, final and binding on us. We further agree that ESIC shall be the sole judge as to whether The Bidder is in default in due and faithful performance of its obligations under The Tender Enquiry and ESIC decision that The Bidder is in default shall be final and binding on us, notwithstanding any differences between ESIC and The Bidder or any disputes between ESIC and The Bidder pending before an arbitrator or any other court or tribunal or authority.
In order to give effect to this Bank Guarantee ESIC shall be entitled to act as if we are the principal debtor and any change in our constitution or that of The Bidder shall not, in any way, or manner affect our liability or obligation under this Bank Guarantee. ESIC shall have liberty, without affecting in any manner our liability under this Bank Guarantee, to vary at any time, the terms and conditions of The Tender Enquiry or to extend the time or period for compliance or to postpone for any time the exercise of any of ESIC rights or enforce or forebear from enforcing any of the terms and conditions of The Tender Enquiry and we shall not be released from our liability or obligation under this Bank Guarantee by any exercise of such liberty by ESIC or other forbearance, indulgence, act or omission on ESIC part.
Any notice by way of request, demand or otherwise hereunder may be sent by post/ email addressed to us at above referred branch, which shall be deemed to have been duly authorized to receive such notice and to effect payment thereof forthwith, and if sent by post it shall be deemed to have been given at the time when it ought to have been delivered in due course of post and in proving such notice, when given by post, it shall be sufficient to prove that the envelope containing the notice was posted and a certificate signed by any of ESIC officers that the envelope was so posted shall be conclusive.
We hereby waive the necessity of ESIC demanding the said debt from The Bidder before presenting us with the demand.
Page 18 of 28
,
/ TelFax: 011-23234334
We further agree that no change or addition to or other modification of the terms of The Tender Enquiry to be performed there under or of any of The Tender Enquiry documents which may be made between ESIC and The Bidder shall in any way release us from any liability under this Bank Guarantee and we hereby waive notice of any such change, addition or modification.
We further agree that no change or addition to or other modification of the terms of The Tender Enquiry to be performed there under or of any of The Tender Enquiry documents which may be made between ESIC and The Bidder shall in any way release us from any liability under this Bank Guarantee and we hereby waive notice of any such change, addition or modification. We undertake not to revoke this Bank Guarantee in whole or in part whatsoever, during its currency. This Bank Guarantee shall be valid up to ______ (day(s) /month(s)/ year(s)) from the date of opening of e-tender i.e. up to ___________ (indicate date).
…………………………………………………………………………………
(Name & Designation of Officer) (Seal, Name & Address of the Bank and Address of the Branch along with e-mail
address of the Issuing Officer)
Page 19 of 28
07DELE00045DIDA
AAAJE0888Q
Account number :- 11084244187 IFSC Code :- SBIN0000691
Page 20 of 28
Company :
NUMBER # TEXT # TEXT # TEXT # NUMBER # TEXT TEXT TEXT TEXT NUMBER NUMBER #
Sl.
No.
offered
NPPA, Enter the Order
Rs. P
1 2 3 5 13 14 15 16 17 18 53
8
Each Vial to contain: Ciprofloxacin 0.3% w/v.
Now to be read as : Ciprofloxacin Eye/Ear Drop-
Each Vial to contain: Ciprofloxacin 0.3% w/v.
5ml to 10ml Vial Item no.: 213
Unit mentioned in
Each gm to contain: Polymixin B Sulphate 5000 IU, Neomycin
Now to be read as : Polymixin, Neomycin Eye Oint-
Each gm to contain: Polymixin B Sulphate 5000 IU, Neomycin
5gm to 10gm tube Item no.: 1251
Unit mentioned in
BOQ was 5gm
Each Vial to contain: Hydroxypropylmethylcellulose 0.3%
Now to be read as : Hydroxypropylmethylcellulose Eye Drop-
Each Vial to contain: Hydroxypropylmethylcellulose 0.3%
5ml to 10ml Vial Item no.: 1927
Unit mentioned in
Each ml to contain: Brinzalamide 1%
Now to be read as :
Brinzolamide Eye Drop-
Each ml to contain: Brinzolamide 1% Item no.: 2273 5 ml Vial
INR Zero Only 0.0000
Total in Figures 0.0000
Quoted Rate in Words
REVISED TEMPLATE BOQ FOR THE ITEMS MENTIONED BELOW AS PER CORRIGENDUM.
PLEASE NOTE THAT IT IS MANDATORY TO CHECK THE REVISED ITEM DESCRIPTION AND/ OR UNITS AS HIGHLIGHTED IN BOLD BELOW FOR QUOTING
THE PRICE IN ONLINE BOQ.
IT SHALL BE THE SOLE RESPONSIBILTY OF THE BIDDER TO QUOTE THE BELOW MENTIONED ITEMS AS PER CHANGES HIGHLIGHTED, IN FINAL ONLINE
PRICEBID SUBMISSION.
Item Wise BoQ DEMO TEMPLATE OF TENDER ENQUIRY 142C FOR INFORMATION TO BIDDERS FOR THE ITEMS DESCRIBED BELOW AS
PER CORRIGENDUM.
PRICE SCHEDULE
(This BOQ template must not be modified/replaced by the bidder and the same should be uploaded after filling the relevent columns, else the bidder is liable to be rejected for this tender. Bidders are allowed to enter the Bidder Name and Values only )
Tender Inviting Authority: DIRECTOR GENERAL, EMPLOYEES' STATE INSURANCE CORPORATION
Name of Work: SUPPLY OF DRUGS & DRESSINGS
Contract No: E-TENDER ENQUIRY FORM FOR RATE CONTRACT NO – 142C
Validate Print Help
Company :
Sl.
No.
offered
Rs. P
1 2 3 5 13 14 15 16 17 18 53
157
Each Tab/Cap to contain: Trimetazidine 60mg
Now to be read as : Trimetazidine Tab/Cap-
Each PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain:
Trimetazidine 60mg Item no.: 2305 1 Tab/Cap
Each Tab/Cap to contain: Pregabalin 75mg
Now to be read as : Pregabalin Tab/Cap-
Each PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain:
Pregabalin 75mg Item no.: 2317 1 Tab/Cap
IT SHALL BE THE SOLE RESPONSIBILTY OF THE BIDDER TO QUOTE THE BELOW MENTIONED ITEMS AS PER CHANGES HIGHLIGHTED, IN FINAL
ONLINE PRICEBID SUBMISSION.
PLEASE NOTE THAT IT IS MANDATORY TO CHECK THE REVISED ITEM DESCRIPTION AND/ OR UNITS AS HIGHLIGHTED IN BOLD BELOW FOR
QUOTING THE PRICE IN ONLINE BOQ.
Item Wise BoQ DEMO TEMPLATE OF TENDER ENQUIRY 143C FOR INFORMATION TO BIDDERS FOR THE ITEMS DESCRIBED BELOW AS
PER CORRIGENDUM.
PRICE SCHEDULE
Validate Print Help
Company :
Sl.
No.
offered
Rs. P
1 2 3 5 13 14 15 16 17 18 53
27
Each PFS to contain: Peg-Filgrastim
Now to be read as : Peg-Filgrastim Inj-
Each PFS to contain: Peg-Filgrastim 6mg Item no.: 1466
Unit mentioned in
Each Tube to contain: Tacrolimus 0.1%
Now to be read as : Tacrolimus Oint-
Each Tube to contain: Tacrolimus 0.1%
5gm to 10 gm tube Item no.: 1709
Unit mentioned in
Item no.: 1652b
Unit mentioned in
PLEASE NOTE THAT IT IS MANDATORY TO CHECK THE REVISED ITEM DESCRIPTION AND/ OR UNITS AS HIGHLIGHTED IN BOLD BELOW FOR QUOTING THE
PRICE IN ONLINE BOQ.
Item Wise BoQ DEMO TEMPLATE OF TENDER ENQUIRY 144C FOR INFORMATION TO BIDDERS FOR THE ITEMS DESCRIBED BELOW AS PER
CORRIGENDUM.
PRICE SCHEDULE
Validate Print Help
Company :
Sl.
No.
offered
Rs. P
1 2 3 5 13 14 15 16 17 18 53
12
Each Kid Tab/Cap to contain: Pyrazinamide 300mg
Now to be read as :
Pyrazinamide Kid PLAIN/DISPERSIBLE Tab/Cap-
Pyrazinamide 300mg Item no.: 191 1 Tab/Cap
Item Description mentioned in BOQ Ringer Lactate Inj-
Each to contain: Ringer Lactate 500ml Self Collapsible IV Fluid PVC
Bag
Each to contain: Ringer Lactate 500ml Self
Collapsible IV Fluid PVC Bag/ Self
Collapsible container (FFS Technology) Item no.: 1726 500ml Bag
Item Wise BoQ DEMO TEMPLATE OF TENDER ENQUIRY 145C FOR INFORMATION TO BIDDERS FOR THE ITEMS DESCRIBED BELOW
AS PER CORRIGENDUM.
PRICE SCHEDULE
Validate Print Help
Page 24 of 28
Item Wise BoQ DEMO TEMPLATE OF TENDER ENQUIRY 145C FOR INFORMATION TO BIDDERS FOR THE ITEMS DESCRIBED BELOW
AS PER CORRIGENDUM.
Validate Print Help
Each to contain: DNS 500ml Self Collapsible IV Fluid Bag
Now to be read as : DNS Inj-
Each to contain:DNS 500ml Self Collapsible IV
Fluid Bag / Self Collapsible container (FFS
Technology) Item no.: 1727 500ml bag
Item Description mentioned in BOQ Dextrose 5% Inj (IV Fluids)-
Each to contain: Dextrose 5% Self Collapsible I.V. Fluid Bag
Now to be read as : Dextrose 5% Inj (IV Fluids)-
Each to contain: Dextrose 5% Self Collapsible I.V.
Fluid Bag/ Self Collapsible container (FFS
Technology) Item no.: 1796 500ml Bag
Each SR Tab/Cap to contain:Nitrofuradantin 100mg
Now to be read as :
Nitrofurantoin SR Tab/Cap-
Each SR Tab/Cap to contain:Nitrofurantoin 100mg Item no.: 1903 1 Tab/Cap
Item Description mentioned in BOQ Darbepoetin Inj-
Each PFS to contain: Darbepoetin Alfa 60mg
Now to be read as : Darbepoetin Inj-
Each PFS to contain: Darbepoetin Alfa 60mcg Item no.: 2381 1 PFS
Page 25 of 28
Company :
Sl.
No.
offered
Rs. P
1 2 3 5 13 14 15 16 17 18 53
38
Item Description mentioned in BOQ Urea+ Lactic Acid Cream-
Each Jar to contain: Urea 12% w/w, Lactic Acid 6% w/w, Glycine 3%
w/w, Ammonium Chloride 0.5% w/w, Sod. Chloride 0.5% w/w,
Potassium Chloride 0.5% w/w, Calcium Lactate 0.5% w/w,
Magnesium Chloride 0.3% w/w, Sod. Dihydrogen Phosphate 0.5 %
w/w
Now to be read as : Urea+ Lactic Acid Cream-
Each Jar to contain: Urea 12% w/w, Lactic Acid 6% w/w, Glycine 3%
w/w, Ammonium Chloride 0.5% w/w, Sod. Chloride 0.5% w/w,
Potassium Chloride 0.5% w/w, Calcium Lactate 0.5% w/w,
Magnesium Chloride 0.3% w/w, Sod. Dihydrogen Phosphate 0.5 %
w/w
Unit mentioned
Now to be read as :
Terbinafine Ointment/Cream - Each tube to contain: Terbinafine Hcl. 1%
Item no.: 1703 10 gm Tube
CORRIGENDUM.
PRICE SCHEDULE
Validate Print Help
CORRIGENDUM.
Each Tube to contain: Adapalene 0.1% w/w (As Microsheres)
Clindamycin Phosphate USP Equivalent To Clindamycin 1.0% w/w
in an Aqueous Gel Base -Q.S.
Now to be read as : Acne Gel-
Each Tube to contain: Adapalene 0.1% IP/BP/USP etc w/w
(As Microsheres) Clindamycin Phosphate IP/BP/USP etc Equivalent To Clindamycin 1.0% w/w in an Aqueous Gel Base -Q.S.
Item no.: 1704 15 gm Tube
Each Cartridge to contain: Somatropin 16 IU (R-DNA Origin)
Now to be read as : Human Growth Hormone-
Each Cartridge to contain: Somatropin 16 IU (R-DNA
Origin) / Somatropin 5.3mg (R-DNA Origin)
Item no.: 509a 1 Cartridge
Page 27 of 28
Company :
Sl.
No.
offered
Rs. P
1 2 3 5 13 14 15 16 17 18 53
25
Item no.: 2055 1 Tab/Cap
Item Wise BoQ DEMO TEMPLATE OF TENDER ENQUIRY 147B FOR INFORMATION TO BIDDERS FOR THE ITEMS DESCRIBED BELOW AS
PER CORRIGENDUM.
PRICE SCHEDULE
Contract No: E-TENDER ENQUIRY FORM FOR RATE CONTRACT NO – 147B
Validate Print Help

Documents

e-TENDER SCHEDULE